Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries

Birgitte K. Giersing*, Richard Isbrucker, David C. Kaslow, Marco Cavaleri, Norman Baylor, Diadié Maiga, Patricia B. Pavlinac, Mark S. Riddle, Gagandeep Kang, Calman A. MacLennan

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries'. Together they form a unique fingerprint.

Medicine & Life Sciences